Dr. Bhupinder Singh Natt, MD

Dr. Natt practices at Banner - University Medical Center South in Tucson, Arizona, part of Banner Health.

Dr. Natt's NPI, 1073820726, was assigned on September 1, 2010. Dr. Natt holds Arizona license 52015.

Dr. Natt's primary practice is Banner - University Medical Center South, at 2800 East Ajo Way, Tucson, AZ 85713 in Pima County. The practice phone is (520) 874-2000.

Dr. Natt's primary practice is Banner - University Medical Center South in Tucson, Arizona, part of Banner Health. Dr. Natt is also affiliated with Banner - University Medical Center Tucson. The medical group on file is Banner Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Natt practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Natt's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Natt is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Natt is licensed in Arizona.

CMS data shows 361 Medicare services from Dr. Natt across 6 procedure codes in 2024, for 161 Medicare patients. Medicare paid $44,022 for them.

CMS counts 161 Medicare patients who saw Dr. Natt in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Natt's median patient age at 65, with 43% women.

In 2024, Dr. Natt wrote 230 Medicare Part D claims for 57 patients. 76% of them were for generic drugs. CMS names the drug for 124 of them, across 5 drugs with 11 or more claims each, at $14,846 in total drug cost. In 2023, CMS named 164 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Natt for performance year 2024, reported through an alternative payment model (APM). Dr. Natt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 29 papers to Dr. Natt, published from 2016 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Extracorporeal Membrane Oxygenation, Respiratory Distress Syndrome and Intubation, Intratracheal. Dr. Natt has published most often in Ann Am Thorac Soc. Dr. Natt's most frequent co-authors are Jarrod Michael Mosier, MD, Christian Bime, MD and Cameron D. Hypes, MD.

Dmand AI links Dr. Natt to 1 clinical trial. Conditions studied include Idiopathic Interstitial Pneumonias and Idiopathic Pulmonary Fibrosis.

CMS Open Payments shows 9 general payments to Dr. Natt from 2 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $606.